GenturaDx has created its scientific advisory board with three initial members: Dr. Keith Jerome, Dr. Steven Miller, and Dr. Gregory Tsongalis. The board will provide expert perspectives across science, laboratory medicine and the commercial market related to initial test development and future applications of the company's proprietary IDbox(TM). The IDbox system is set to begin clinical trials in 2012.

"We are honored to have attracted these renowned scientists and industry leaders who bring a broad perspective to our work and will lend their expertise enabling GenturaDx to bring its fully integrated platform into the clinical laboratory," said Geoff McKinley, Ph.D., Sr. VP of R&D.